Dr. Foyt is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3550 General Atomics Court
San Diego, CA 92121
Education & Training
National Institutes of Health Clinical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1991
Baylor College of MedicineResidency, Internal Medicine, 1985 - 1988- Baylor College of MedicineClass of 1985
Certifications & Licensure
TX State Medical License 1986 - 2026
CA State Medical License 2007 - 2025
MI State Medical License 1997 - 2004
MD State Medical License 1989 - 1992
Publications & Presentations
PubMed
- 19 citationsEncapsulated stem cell-derived β cells exert glucose control in patients with type 1 diabetes.Bart Keymeulen, Kaat De Groot, Daniel Jacobs-Tulleneers-Thevissen, David M Thompson, Melena D Bellin
Nature Biotechnology. 2024-10-01 - 128 citationsInsulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation deviceA. M. James Shapiro, David M. Thompson, Thomas Donner, Melena D. Bellin, Willa A. Hsueh
Cell Reports. Medicine. 2021-12-02 - 57 citationsLong-Acting C-Peptide and Neuropathy in Type 1 Diabetes: A 12-Month Clinical TrialJohn Wahren, Howard Foyt, Mark Daniels, Joseph C. Arezzo
Diabetes Care. 2016-04-01
Press Mentions
San Diego Biotech Working on ‘Functional Cure’ for Type 1 Diabetes Sold to Rival for $320MJuly 12th, 2022- Vertex to Acquire ViaCyte for $320M, Growing Diabetes Cell Therapy PipelineJuly 11th, 2022
- ViaCyte Appoints Dr. Jon Wilensky as Head of SurgeryJuly 21st, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
